458 related articles for article (PubMed ID: 20951911)
1. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.
Scarpignato C; Hunt RH
Gastroenterol Clin North Am; 2010 Sep; 39(3):433-64. PubMed ID: 20951911
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.
Sostres C; Gargallo CJ; Arroyo MT; Lanas A
Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):121-32. PubMed ID: 20227026
[TBL] [Abstract][Full Text] [Related]
3. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
Fiorucci S
Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
6. Drug-related damage of the ageing gastrointestinal tract.
Sostres C; Gargallo C; Lanas A
Best Pract Res Clin Gastroenterol; 2009; 23(6):849-60. PubMed ID: 19942163
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Jones R; Rubin G; Berenbaum F; Scheiman J
Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
[TBL] [Abstract][Full Text] [Related]
8. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs.
Peura DA; Goldkind L
Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S7-13. PubMed ID: 16168079
[TBL] [Abstract][Full Text] [Related]
9. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
10. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
[TBL] [Abstract][Full Text] [Related]
11. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
Scheiman JM
Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
[TBL] [Abstract][Full Text] [Related]
12. The NSAID dilemma: managing osteoarthritis in high-risk patients.
Roth SH; Anderson S
Phys Sportsmed; 2011 Sep; 39(3):62-74. PubMed ID: 22030942
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
14. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
Rostom A; Moayyedi P; Hunt R;
Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
[TBL] [Abstract][Full Text] [Related]
15. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
16. Use of nonsteroidal antiinflammatory drugs: is there a change in patient risk profile after withdrawal of rofecoxib?
Rahme E; Roussy JP; Lafrance JP; Nedjar H; Morin S
J Rheumatol; 2011 Feb; 38(2):195-202. PubMed ID: 21078717
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
[TBL] [Abstract][Full Text] [Related]
18. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs-induced gastrointestinal damage. Review.
Arroyo M; Lanas A
Minerva Gastroenterol Dietol; 2006 Sep; 52(3):249-59. PubMed ID: 16971869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
